Emergency Guidelines for the Campus Community
Communications to Freshman Scholars Institute
Friday, July 11
Meningitis B vaccine dates and information
Between March 2013 and March 2014, nine cases of serogroup B meningococcal disease have been associated with Princeton University. There have been no cases occurring on campus or affecting Princeton students since November 2013.
Meningitis B is not covered by the vaccine that is required for teenagers in the US. There is no vaccine for meningitis B licensed in the US; however, beginning in December 2013, the US Food and Drug Administration (FDA) and the US Centers for Disease Control and Prevention (CDC) allowed the University to import a meningitis B vaccine that is licensed in Europe, Australia and Canada, but not in the US.
The CDC recommends that all Princeton University undergraduate students receive a vaccine that helps protect against meningococcal disease caused by serogroup B bacteria
The first dose of the Meningitis B vaccine for incoming students will be available on Tuesday, July 15 in McCosh Health Center, room G20. The schedule is based on the first initial of the last name:
A-G: 1:30 to 2:30 p.m.
Princeton University will cover the cost of the vaccine. Because protection provided by the first dose declines over time, two doses of the vaccine are needed for full immunity. The second dose will be made available at a later date. Students under the age of 18 will need a signed consent form from their parent or guardian before receiving the vaccine.
Students can help prevent the spread of bacterial meningitis by doing the following:
If you or a close contact becomes sick: